Key result
Bioinformatics analysis links CLU and GUCY1B3 to T cell proliferation in atherosclerosis.
Answers are grounded in this paper and cite their sources.
Bioinformatics analysis identified CLU and GUCY1B3 as potential biomarkers for T cell proliferation in atherosclerosis, which may aid in predicting disease risk.
BACKGROUND: Atherosclerosis (AS) is a complex chronic disease caused by the development of atherosclerotic plaques. T cell proliferation exerts a vital influence on development of the AS. This research aimed to conduct a comprehensive analysis to computationally screen candidate T cell proliferation-related biomarkers in AS and to explore their potential molecular mechanisms. METHODS: The transcriptional datasets of AS patients were obtained from the Gene Expression Omnibus (GEO) repository. To identify differentially expressed-T cell proliferation-related genes (DE-TPRGs), we integrated differential gene expression analysis with weighted gene co-expression network analysis (WGCNA), taking the intersection of DEGs and WGCNA-derived T cell proliferation-related module genes (TRMGs). Biomarkers were selected and validated through machine learning algorithms and expression levels. Moreover, a nomogram for predicting AS risk was developed based on the biomarkers. Enrichment analysis was employed to examine relevant pathways, while immune cell infiltration analysis was conducted to investigate the connection between immune cells and biomarkers. Finally, the construction of molecular regulatory and compound prediction networks, as well as molecular docking and molecular dynamic simulations, further validated the key regulatory roles of biomarkers in AS. RESULTS: Overall, two candidate genes (CLU and GUCY1B3) were determined to be potentially associated with the progression of AS. The nomogram constructed from these biomarkers showed good performance in predicting AS risk. Reactome rRNA processing and reactome translation were notably enriched in the pathways related to two biomarkers. CLU and GUCY1B3 showed positive computational corrections with activated dendritic cells, suggesting a possible involvement of these immune processes in AS. Moreover, 50 miRNAs (like hsa-miR-4504) and 68 transcription factors (TFs) (like MYB and TAL1) were found to have relationships with biomarkers. Importantly, the results and molecular dynamics simulation analyses predicted potential binding interactions between these candidate genes and bisphenol A, with GUCY1B3 demonstrating relatively greater binding stability. CONCLUSIONS: The bioinformatics findings suggested that CLU and GUCY1B3 may serve as candidate biomarkers warranting further experimental investigation in AS associated with T cell proliferation.
No takes yet. Share an insight, caveat, or question.
Xiong et al. (2026) studied Atherosclerosis. CLU and GUCY1B3 biomarkers was evaluated on Identification of candidate T cell proliferation-related biomarkers. Bioinformatics analysis identified CLU and GUCY1B3 as candidate biomarkers associated with T cell proliferation in atherosclerosis, showing potential binding interactions with bisphenol A.
Synapse has enriched 10 related papers. Consider them for comparative context: